Insider trading

Period: 120 months Stock: AXGN Role: Other officers × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

36 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

36 decisions over 120 months Remove this filter
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

36 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

36 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
36 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
36 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

36 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
10 Aug 2026
Began Marc A EVP & General Counsel
Sold on a plan
$3.20M 67,500 at 47.35
57.4%
Sold half or more
7 May 2026
Kemp Jens Chief Marketing Officer
Sold at will
$173.76K 4,000 at 43.44
5.2%
Not planned
7 May 2026
Sold at will
$168.72K 3,878 at 43.51
4.0%
Not planned
16 Mar 2026
DeVinney Erick Wayne Chief Innovation Officer
Sold at will
$171.46K 5,221 at 32.84
1.9%
Not planned
11 Dec 2025
Began Marc A EVP & General Counsel
Sold at will
$396.66K 13,222 at 30.00
42.0%
Not planned
9 Dec 2025
DeVinney Erick Wayne Chief Innovation Officer
Sold at will
$609.09K 19,517 at 31.21
7.5%
Not planned
9 Dec 2025
Began Marc A EVP & General Counsel
Sold at will
$289.55K 9,278 at 31.21
22.7%
Not planned
9 Dec 2025
Kemp Jens Chief Marketing Officer
Sold at will
$254.53K 8,156 at 31.21
15.1%
Not planned
16 Sep 2025
DeVinney Erick Wayne Chief Innovation Officer
Sold at will
$18.52K 1,137 at 16.29
0.5%
Not planned
19 Mar 2025
DeVinney Erick Wayne Chief Innovation Officer
Sold at will
$264.44K 15,111 at 17.50
6.5%
Not planned
21 Mar 2024
Scopelianos Angelo Chief R&D Officer
Sold at will 3×
$52.85K 6,881 at 7.68
11.5%
Not planned
21 Mar 2024
Donovan Michael Patrick VP Operations
Sold at will 3×
$46.33K 6,033 at 7.68
13.7%
Not planned
21 Mar 2024
DeVinney Erick Wayne Chief Innovation Officer
Sold at will 3×
$35.16K 4,578 at 7.68
2.7%
Not planned
7 Mar 2024
Donovan Michael Patrick VP Operations
Sold at will
$319.89K 36,310 at 8.81
50.4%
Sold half or more
21 Jul 2021
Donovan Michael Patrick VP Operations
Sold, plan not stated
$38.78K 1,935 at 20.04
4.5%
4 Jun 2021
MARTINEZ MARIA D. Chief Human Resources Officer
Sold, plan not stated
$50.02K 2,652 at 18.86
47.5%
18 Feb 2021
Donovan Michael Patrick VP Operations
Sold, plan not stated
$34.62K 1,808 at 19.15
4.2%
30 Dec 2020
Donovan Michael Patrick VP Operations
Sold, plan not stated
$30.29K 1,733 at 17.48
6.2%
29 Dec 2020
Billet Isabelle Chief Strategy and BD Officer
Sold, plan not stated
$11.56K 649 at 17.81
6.4%
29 Dec 2020
MARTINEZ MARIA D. Chief Human Resources Officer
Sold, plan not stated
$10.10K 567 at 17.81
10.8%
29 Dec 2020
Friedman Mark Louis VP,Regulatory & Quality
Sold, plan not stated
$10.10K 567 at 17.81
4.8%
29 Dec 2020
Scopelianos Angelo VP Research & Development
Sold, plan not stated
$10.10K 567 at 17.81
9.3%
29 Dec 2020
Donovan Michael Patrick VP Operations
Sold, plan not stated
$10.10K 567 at 17.81
2.0%
29 Dec 2020
DeVinney Erick Wayne VP, Clinical&Translational Sc
Sold, plan not stated
$6.61K 371 at 17.81
0.6%
22 Dec 2020
Donovan Michael Patrick VP Operations
Sold, plan not stated
$4.80K 279 at 17.19
1.1%
21 Dec 2020
DeVinney Erick Wayne VP, Clinical&Translational Sc
Sold, plan not stated
$2.41K 147 at 16.42
0.2%
21 Dec 2020
Donovan Michael Patrick VP Operations
Sold, plan not stated
$1.58K 96 at 16.42
0.4%
21 Dec 2020
Friedman Mark Louis VP,Regulatory & Quality
Sold, plan not stated
$1.58K 96 at 16.42
1.1%
9 Nov 2020
Donovan Michael Patrick VP Operations
Sold, plan not stated
$264.26K 17,617 at 15.00
40.4%
14 Aug 2019
MARTINEZ MARIA D. Chief Human Resources Officer
Bought
$30.26K 2,000 at 15.13
opened
First buy on file
13 Aug 2019
Billet Isabelle Chief Strategy and BD Officer
Bought 13×
$85.14K 5,635 at 15.11
opened
First buy on file
13 Jun 2019
Donovan Michael Patrick VP Operations
Sold, plan not stated
$400.00K 20,000 at 20.00
51.3%
Sold half or more
13 May 2019
Hansen David K VP Finance & Treasurer
Sold, plan not stated
$452.60K 20,000 at 22.63
43.9%
30 Nov 2018
Freitag Gregory Gene General Counsel
Sold, plan not stated
$1.49M 45,000 at 33.00
31.9%
15 Nov 2018
Freitag Gregory Gene General Counsel
Sold, plan not stated
$645.00K 20,000 at 32.25
12.4%
16 May 2018
MCCARREY SHAWN F SVP Sales
Sold, plan not stated
$434.70K 10,000 at 43.47
23.2%
Showing 1–36 of 36.